Lumen director granted 25,197 restricted shares
Lumen Technologies director Kevin P. Chilton received an equity grant rather than buying shares on the market.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lumen Technologies director Kevin P. Chilton received an equity grant rather than buying shares on the market. On this Form 4, he acquired 25,197 shares of Common Stock as a compensation-related grant valued at $9.44 per share. These are restricted stock units that will vest on May 21, 2027 and be settled in shares later under his deferral election. After this award, his direct holdings increased to 436,716 shares, indicating this is a routine incentive grant that raises his long-term equity stake in the company.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 25,197 | $9.44 | $238K |
Footnotes (1)
- F1. This grant of restricted stock units will vest on May 21, 2027, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.
Key Figures
Key Terms
restricted stock units financial
Form 4 regulatory
grant, award, or other acquisition regulatory
deferral election financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Lumen Technologies (LUMN) disclose in Kevin P. Chilton’s latest Form 4?
Was Kevin P. Chilton buying or selling Lumen Technologies (LUMN) stock in this Form 4?
How large is Kevin P. Chilton’s new equity award in Lumen Technologies (LUMN)?
When do Kevin P. Chilton’s new Lumen Technologies (LUMN) restricted stock units vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.